Share this post on:

Name :
Anti-BRF1 antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
Rabbit polyclonal antibody to BRF1

Tested applications :
WB, IHC-P, IF

Species reactivity :
Human, Mouse

Alternative names :
BRF antibody; CFDS antibody; hBRF antibody; BRF-1 antibody; GTF3B antibody; TAF3C antibody; TAF3B2 antibody; TF3B90 antibody; TAFIII90 antibody; TFIIIB90 antibody; HEL-S-76p antibody

Immunogen :

Isotype :
IgG

Preparation :
This antigen of this antibody was the antiserum was produced against synthesized peptide derived from human tf3b. aa range:231-280

Clonality :
Polyclonal

Formulation :
Liquid, Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Storage instructions :
Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.

Applications :
WB: 1:500-1:2000IHC-P: 1:100-1:300IF: 1:100-1:500

Background :
Q92994

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Thioredoxin Antibody
alpha smooth muscle Actin Antibody
ox-LDL Antibody: ox-LDL Antibody is an unconjugated, approximately 31 kDa, rabbit-derived, anti-ox-LDL polyclonal antibody. ox-LDL Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, background without labeling.

Share this post on:

Author: Gardos- Channel